VeriMomIst chamomilla recutita flower/leaf extract in der Schwangerschaft sicher?
No harmonised CLP reproductive classification (ECHA Annex VI) and no SCCS/SCCS-like or CIR conclusion indicating reproductive hazard; CIR has assessed chamomile/Chamomilla extracts as safe as used in cosmetics. Although components (flavonoids such as apigenin) show weak in vitro estrogenic activity in some studies, there is no convincing in vivo reproductive or teratogenic evidence to raise hazard scoring, so hazard and mechanism are scored 0; low but measurable dermal exposure from topical cosmetic use is scored e=1 (PubChem/CosIng product composition and typical extract constituents suggest small molecule components able to be absorbed at low levels).
Pregnancy-safe products containing chamomilla recutita flower/leaf extract
Related ingredients
Frequently asked questions
- Ist chamomilla recutita flower/leaf extract in der Schwangerschaft sicher?
- No harmonised CLP reproductive classification (ECHA Annex VI) and no SCCS/SCCS-like or CIR conclusion indicating reproductive hazard; CIR has assessed chamomile/Chamomilla extracts as safe as used in cosmetics. Although components (flavonoids such as apigenin) show weak in vitro estrogenic activity in some studies, there is no convincing in vivo reproductive or teratogenic evidence to raise hazard scoring, so hazard and mechanism are scored 0; low but measurable dermal exposure from topical cosmetic use is scored e=1 (PubChem/CosIng product composition and typical extract constituents suggest small molecule components able to be absorbed at low levels).
- Ist chamomilla recutita flower/leaf extract während des Stillens sicher?
- Same rationale as pregnancy: no regulatory reproductive classification or CIR/SCCS contraindication for topical cosmetic use. Low but measurable maternal dermal absorption is possible; systemic transfer into milk is not demonstrated for cosmetic topical use. Breastfeeding exposure therefore scored as low (e=1).
- Ist chamomilla recutita flower/leaf extract sicher für Babyhaut?
- No infant-specific safety signals or regulatory reproductive/ developmental classifications. Because infant skin has a higher surface-area-to-weight ratio and a less mature barrier, exposure score is increased by +1 versus adults (adult e=1 → infant e=2), although there are no data showing specific harm to 0–3 year olds from topical chamomile extracts used cosmetically. CIR assessment supports safety as used.
- Wie bewertet VeriMom chamomilla recutita flower/leaf extract?
- VeriMom bewertet chamomilla recutita flower/leaf extract mit 93/100 (keine bekannten Risiken) basierend auf EU CosIng, ECHA-Klassifizierungen und PubMed-Studien.
- Was sind schwangerschaftssichere Alternativen zu chamomilla recutita flower/leaf extract?
- Siehe unsere kuratierte Liste der schwangerschaftssicheren Alternativen zu chamomilla recutita flower/leaf extract basierend auf ähnlicher Funktion.
Prüfe jede Zutatenliste in 2 Sekunden
Lade VeriMom kostenlos — scanne jedes Produkt und sieh sofort die Schwangerschafts-Sicherheitsbewertung.
Medizinischer Haftungsausschluss
Diese Informationen dienen ausschließlich Bildungszwecken und stellen keine medizinische Beratung dar. Sicherheitsbewertungen basieren auf öffentlich zugänglichen Daten und spiegeln möglicherweise nicht alle Risiken wider. Konsultieren Sie immer Ihren Arzt, bevor Sie ein Produkt während der Schwangerschaft oder Stillzeit verwenden.